Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Voices From TCT 2015: FDA's Bram Zuckerman On Benefit-Risk Assessments And Approaching FDA Early

This article was originally published in The Gray Sheet

Executive Summary

“The Gray Sheet” talks to FDA cardiovascular device review lead Bram Zuckerman about his decades-long experience at the agency, the future of cardiac devices and why some companies are hesitant about talking to FDA early on about their product development in this podcast interview from the Transcatheter Cardiovascular Therapeutics meeting in San Francisco.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst